Compare Becton Dickinson and Co (BDX) vs YieldMax MSTR Option Income Strategy ETF (MSTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs YieldMax MSTR Option Income Strategy ETF — how do they compare? Becton Dickinson and Co trades at $149.95 (market cap $41.51B), while YieldMax MSTR Option Income Strategy ETF trades at $13.38. The key difference: Becton Dickinson and Co pays a 2.79% dividend while YieldMax MSTR Option Income Strategy ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| BDX | MSTY | |
|---|---|---|
Market Cap | $41.51B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $185.39 | $114.30 |
52-Week Low | $135.49 | $11.55 |
Enterprise Value | $57.97B | — |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
MSTY trades at $12.57, down 2.03% with bearish technical signals from moving averages. The ETF maintains aggressive weekly dividend distributions, though recent coverage highlights concerns about return of capital and NAV erosion. Technical indicators show RSI in neutral territory while moving averages signal continued downward pressure.
The outlook remains challenging with structural risks to the covered-call strategy capping upside potential while exposing investors to full downside. Recent analyst commentary emphasizes unsustainable yield dynamics and dependence on Bitcoin volatility. Investment requires careful consideration of distribution sustainability versus capital preservation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About YieldMax MSTR Option Income Strategy ETF
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →
